NIAID Pledges $26M for Biodefense | GenomeWeb
NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Disease will provide up to $26 million to cooperative research partnerships that address biodefense and emerging infectious disease issues.
The program aims to develop diagnostics, vaccines, therapeutics, and immunotherapeutics specific to Category A, B, and C pathogens or toxins.
The $26 million will fund between 15 and 20 awards, and the size and duration of these awards will vary.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.